Jiawang Ou
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: February 20, 2025
Cumulative Dose of PEG-asparaginase Is Associated with Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.
Journal: Transplantation and cellular therapy
Published: December 12, 2024
Refining Risk Stratification for B-cell Precursor Adult Acute Lymphoblastic Leukemia Treated With a Pediatric-inspired Regimen by Combining IKZF1 Deletion and Minimal Residual Disease.
Journal: Transplantation and cellular therapy
Published: June 24, 2024
Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort.
Journal: Haematologica
Published: April 04, 2024
STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: December 20, 2023
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: December 03, 2023
Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
Journal: Leukemia & lymphoma
Published: November 08, 2023
Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Journal: Cancer medicine
Published: November 01, 2022
Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: September 13, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026